Edmond DE Rothschild Holding S.A. purchased a new position in shares of AMETEK, Inc. (NYSE:AME - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,000 shares of the technology company's stock, valued at approximately $361,000.
Several other large investors have also recently made changes to their positions in AME. Itau Unibanco Holding S.A. grew its position in AMETEK by 62.6% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company's stock worth $34,000 after acquiring an additional 77 shares during the last quarter. Versant Capital Management Inc grew its holdings in shares of AMETEK by 3,116.7% in the fourth quarter. Versant Capital Management Inc now owns 193 shares of the technology company's stock worth $35,000 after purchasing an additional 187 shares during the last quarter. AdvisorNet Financial Inc increased its stake in shares of AMETEK by 1,176.5% in the fourth quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company's stock worth $39,000 after buying an additional 200 shares during the period. Geneos Wealth Management Inc. raised its holdings in AMETEK by 42.9% during the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company's stock valued at $42,000 after buying an additional 70 shares during the last quarter. Finally, OFI Invest Asset Management purchased a new stake in AMETEK during the 4th quarter valued at $43,000. 87.43% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at AMETEK
In other AMETEK news, Director Thomas A. Amato sold 710 shares of the firm's stock in a transaction dated Thursday, March 27th. The stock was sold at an average price of $176.64, for a total transaction of $125,414.40. Following the transaction, the director now owns 10,560 shares in the company, valued at approximately $1,865,318.40. This trade represents a 6.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven W. Kohlhagen sold 1,320 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $189.41, for a total value of $250,021.20. Following the sale, the director now directly owns 22,029 shares in the company, valued at $4,172,512.89. The trade was a 5.65 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.57% of the company's stock.
Analyst Ratings Changes
A number of research analysts have weighed in on AME shares. Truist Financial upped their target price on AMETEK from $221.00 to $222.00 and gave the stock a "buy" rating in a report on Thursday, January 16th. Bank of America raised AMETEK from a "neutral" rating to a "buy" rating and raised their price target for the company from $195.00 to $225.00 in a report on Monday, December 16th. StockNews.com raised AMETEK from a "hold" rating to a "buy" rating in a research note on Thursday. Robert W. Baird cut their price target on shares of AMETEK from $200.00 to $197.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Finally, BNP Paribas upgraded shares of AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 price target for the company in a report on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $204.67.
Check Out Our Latest Research Report on AME
AMETEK Stock Performance
Shares of AME traded down $9.04 during midday trading on Friday, hitting $152.45. 2,753,011 shares of the stock traded hands, compared to its average volume of 1,244,975. The business's 50 day moving average price is $181.27 and its two-hundred day moving average price is $180.90. The firm has a market capitalization of $35.18 billion, a PE ratio of 25.71, a price-to-earnings-growth ratio of 2.73 and a beta of 1.14. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.75 and a current ratio of 1.24. AMETEK, Inc. has a 1-year low of $149.03 and a 1-year high of $198.33.
AMETEK (NYSE:AME - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.02. The company had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.82 billion. AMETEK had a net margin of 19.83% and a return on equity of 16.94%. The business's revenue was up 1.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.68 EPS. Equities research analysts predict that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK declared that its board has authorized a share repurchase program on Friday, February 7th that permits the company to buyback $1.25 billion in shares. This buyback authorization permits the technology company to buy up to 2.9% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's leadership believes its stock is undervalued.
AMETEK Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Friday, March 14th were given a $0.31 dividend. This is a positive change from AMETEK's previous quarterly dividend of $0.28. The ex-dividend date was Friday, March 14th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.81%. AMETEK's dividend payout ratio (DPR) is currently 20.91%.
About AMETEK
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Stories

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report